Back
State Street SPDR S&P Regional Banking ETF Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Buy
61
KRE
State Street SPDR S&P Regional Banking ETF
Last Price:
$66.73
Seasonality Move:
-1.82%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.33
Seasonality Move:
6.08%
Buy
61
State Street SPDR S&P Regional Banking ETF (KRE)
is a Buy
Is State Street SPDR S&P Regional Banking ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Regional Banking ETF [KRE] share price is $66.73. The Score for KRE is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
KRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.32. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KRE Stock Price Chart
What is State Street SPDR S&P Regional Banking ETF's stock price today?
-
The State Street SPDR S&P Regional Banking ETF share price today is $66.73The current trend is moderately bullish and KRE is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.44 | Buy |
| Relative Strength Index (14 RSI): | 63.89 | Buy |
| Chaikin Money Flow: | 1160190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.95 - 67.17) | Buy |
| Bollinger Bands (100): | (60.4 - 65.42) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.69 | Buy |
| Relative Strength Index (14 RSI): | 57.4 | Buy |
| Chaikin Money Flow: | 705480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 22.53) | Buy |
| Bollinger Bands (100): | (17.77 - 22.29) | Buy |
KRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.15 | Sell |
| 20-day SMA: | 65.61 | Buy |
| 50-day SMA: | 62.56 | Buy |
| 200-day SMA: | 60.14 | Buy |
| 8-day EMA: | 66.87 | Sell |
| 20-day EMA: | 65.59 | Buy |
| 50-day EMA: | 62.87 | Buy |
| 200-day EMA: | 40.53 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.49 | Buy |
| 20-day SMA: | 21.54 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.87 | Sell |
| 8-day EMA: | 16.81 | Buy |
| 20-day EMA: | 9.68 | Buy |
| 50-day EMA: | 4.56 | Buy |
| 200-day EMA: | 1.24 | Buy |
State Street SPDR S&P Regional Banking ETF Earnings Growth & KRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
State Street SPDR S&P Regional Banking ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||